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logPLeucine is a major amino acid in nutrients and proteins and is also an important precursor of higher alcohols
during brewing. In Saccharomyces cerevisiae, leucine uptake is mediated by multiple amino acid permeases, in-
cluding the high-afﬁnity leucine permease Bap2. Although BAP2 transcription has been extensively analyzed,
the mechanisms by which a substrate is recognized and moves through the permease remain unknown. Recently,
we determined 15 amino acid residues required for Tat2-mediated tryptophan import. Herewe introduced homol-
ogousmutations into Bap2 amino acid residues and showed that 7 residues played a role in leucine import. Residues
I109/G110/T111 and E305were locatedwithin the putativeα-helix break in TMD1and TMD6, respectively, accord-
ing to the structurally homologous Escherichia coli arginine/agmatine antiporter AdiC. Upon leucine binding, these
α-helix breakswere assumed tomediate a conformational transition in Bap2 from an outward-open to a substrate-
binding occluded state. Residues Y336 (TMD7) and Y181 (TMD3) were located near I109 and E305, respectively.
Bap2-mediated leucine import was inhibited by some amino acids according to the following order of severity:
phenylalanine, leucine N isoleucine N methionine, tyrosine N valine N tryptophan; histidine and asparagine had
no effect. Moreover, this order of severity clearly coincided with the logP values (octanol–water partition coefﬁ-
cients) of all amino acids except tryptophan. This result suggests that the substrate partition efﬁciency to the buried
Bap2 binding pocket is the primary determinant of substrate speciﬁcity rather than structural amino acid side chain
recognition.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Leucine is amajor amino acid in nutrients and proteins and is believed
to account for approximately 20% of our protein intake [1]. Hence, organ-
ismswould be expected to have developed subtlemechanisms of leucine
uptake and synthesis to fulﬁll the high demand for protein synthesis.
Branched-chain amino acids including leucine, isoleucine, and valine
are highly important in brewing because they are precursors of thehigher
alcohols, which in many cases, determine the ﬂavors of alcoholic bever-
ages. In Saccharomyces cerevisiae, these amino acids can be imported by
multiple amino acid permeases, including the general amino acid perme-
ase Gap1 [2], the branched-chain amino acid permeases Bap2 [3] and
Bap3 [4], the tryptophan/tyrosine permease Tat1 [5], the low-afﬁnity
amino acid permease Agp1 [6], and the high-afﬁnity glutamine permease
Gnp1 [7]. Gap1 is active on poor nitrogen sources such as proline, urea, or, Sagamihara 252-5258, Japan.citrulline but is downregulated byubiquitination on rich nitrogen sources
such as ammonium ions, glutamine, or asparagine [8]. Eventually, under
brewing conditions, amino acid permeases other than Gap1, most proba-
bly Bap2, Bap3, and Tat1, are thought to be the main contributors to
branched-chain amino acid uptake. Bap2 is known as a high-afﬁnity leu-
cine permease; Bap3 is the closest homolog of Bap2 and is believed to
have arisen from whole genome duplication [9]. Transcription of BAP2
and BAP3 is induced by amino acids such as leucine or phenylalanine
and is under the control of the external amino acid-sensing plasmamem-
brane Ssy1–Ptr3–Ssy5 complex [10]. Constitutive BAP2 expression in a
brewing yeast strain accelerates the assimilation of branched-chain
amino acids during the brewing process. Bap2 is also regulated by
ubiquitination at the posttranslational level; speciﬁcally, it undergoes
Rsp5-dependent ubiquitination at its N-terminal lysine residues and
subsequent endocytosis, followed by vacuolar degradation [11,12].
Therefore, subtle mechanisms regulate the cellular Bap2 level to control
the branched-chain amino acid uptake in response to different external
nitrogen source qualities.
Reportedly, commonly used laboratory strains such as BY4741
or W303 exhibited growth sensitivity to a synthetic complete (SC)
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acids [13]. The growth sensitivity was due to compromised leucine up-
take in leucine auxotrophic strains; leucine likely competed with other
amino acids, most probably isoleucine and valine, for Bap2 uptake.
Strains carrying leu2 are more sensitive than LEU2 strains to acetic
acid, a yeast fermentation by-product. At a concentration of 80 mM
acetic acid at pH 4.8, leucine, lysine, histidine, tryptophan, phosphate,
and glucose uptake were decreased to 5%–50% of that observed in
cells in the absence of acetic acid [14]. Whether a particular auxotrophy
caused acetic acid-mediated growth inhibition seemed to depend
largely but not solely on the implicated amino acids. Although the
regulatory mechanisms of BAP2 transcription and the physiological im-
portance of leucine availability have been extensively investigated, sub-
strate speciﬁcity and the structure and mechanisms of Bap2-mediated
leucine import remain unclear.
Crystallographic information regarding homologous proteins
has provided uswith clues about themechanical properties of substrate
import through structurally unknown permeases. Using random
mutagenesis in combination with site-directed mutagenesis based on
crystallographic studies of the Escherichia coli arginine/agmatine
antiporter AdiC [15,16], we recently identiﬁed 15 amino acid residues
in the Tat2 transmembrane domains (TMDs) 1,−3,−5–8, and−10
that were required for tryptophan import [17]. Residues T98, Y167,
and E286 were assumed to form the central cavity of Tat2. G97/T98
and E286 were located within the putative α-helix break in TMD1 and
TMD6, respectively, which are highly conserved among yeast amino
acid permeases and bacterial solute transporters. Given the pronounced
similarity between Bap2 and Tat2, with an identity of 39%, these perme-
ases are expected to share mechanistic principles with regard to sub-
strate import. Hence, we created homologous mutations into Bap2 to
elucidate the required amino acid residues for leucine import. This
comparative study on multiple permeases offers clues about the mech-
anisms of substrate recognitionmediated by amino and carboxyl groups
or speciﬁc side chains. In this study, we determined that 7 amino acid
residues in the TMDs were required for Bap2-mediated high-afﬁnity
leucine import. We also proposed the hypothesis that Bap2 substrateTable 1
Plasmids used in this study.
Plasmid Description
pRS316 URA3 CEN
pAK162 3HA, URA3 CEN
pUA99 GFP, URA3 CEN
pYU65 3HA-BAP2 driven by BAP2 promoter in
pAM14 3HA-BAP2 I109T driven by BAP2 promo
pAM15 3HA-BAP2 G110V driven by BAP2 prom
pAM16 3HA-BAP2 T111A driven by BAP2 prom
pAM17 3HA-BAP2 L113S driven by BAP2 prom
pAM18 3HA-BAP2 Y181L driven by BAP2 prom
pAM19 3HA-BAP2 C182A driven by BAP2 prom
pYU58 3HA-BAP2 K242R driven by BAP2 prom
pYU59 3HA-BAP2 E305D driven by BAP2 prom
pYU66 3HA-BAP2 Y336L driven by BAP2 prom
pYU61 3HA-BAP2 I341L driven by BAP2 promo
pYU62 3HA-BAP2 I343L driven by BAP2 promo
pYU63 3HA-BAP2 F345L driven by BAP2 prom
pYU64 3HA-BAP2 V347L driven by BAP2 prom
pAM12 3HA-BAP2 S393G driven by BAP2 prom
pAM20 3HA-BAP2 V394A driven by BAP2 prom
pAM21 3HA-BAP2W496L driven by BAP2 prom
pAM22 3HA-BAP2 T470A driven by BAP2 prom
pUA196 3HA-BAP2-GFP driven by BAP2 promot
pUA197 3HA-BAP2-GFP I109T driven by BAP2 p
pUA198 3HA-BAP2-GFP G110V driven by BAP2
pUA199 3HA-BAP2-GFP T111A driven by BAP2
pUA200 3HA-BAP2-GFP Y181L driven by BAP2 p
pUA201 3HA-BAP2-GFP E305D driven by BAP2
pUA202 3HA-BAP2-GFP Y336L driven by BAP2 p
pUA203 3HA-BAP2-GFP V394A driven by BAP2selectivity is governed by the logP (octanol–water partition coefﬁcient)
of free amino acids.
2. Materials and methods
2.1. Yeast strains and culture conditions
The parental wild-type strain BY4741 (MATa his3Δ0 leu2Δ0
met15Δ0 ura3Δ0) and the deletion mutant bap2Δ::KanMX on the
BY4741 genetic background were used in this study [18]. Unless
otherwise speciﬁed, the cells were grown at 25 °C with shaking in
synthetic complete (SC) medium, with slight modiﬁcations. The
amino acid concentrationswere as follows: 40 or 100 μg·mL−1 leucine,
30 μg·mL−1 isoleucine, 150 μg·mL−1 valine, 40 μg·mL−1 tryptophan,
20 μg·mL−1 histidine, 30 μg·mL−1 lysine, 20 μg·mL−1 methionine,
50 μg·mL−1 phenylalanine, 30 μg·mL−1 tyrosine, 20 μg·mL−1
arginine, 100 μg·mL−1 aspartic acid, 100 μg·mL−1 glutamic acid,
400 μg·mL−1 serine, and 200 μg·mL−1 threonine. Hereafter, SC 40Leu
and SC 100Leu denote SC medium containing 40 and 100 μg·mL−1
leucine, respectively. In our analysis, an OD600 of 1 is comparable to
1.65 × 107 cells mL−1.
2.2. Plasmid construction
The plasmids used in this study are listed in Table 1. pAK162
(pTDH3-3HA in pRS316 [19], [CEN4 URA3], a kind gift from Akio Kihara
of Hokkaido University) was used to create the BAP2 plasmid. First, the
BAP2 open-reading frame (ORF), along with its own promoter (pBAP2,
840-bp upstream of the ORF) and terminator (tBAP2, 440-bp down-
stream of the ORF) regions, was ampliﬁed from strain BY4741 genomic
DNA, using the primers AACAGTCGACTCGGGCTTTCGTTGCCACTC and
ATAGGGTACCTTCATGATGGCCTCCTAGTC. The resulting DNA fragment
was cloned into the pGEM-T Easy vector (Promega, Madison, WI, USA)
to yield pYU1. A DNA fragment containing the BAP2 ORF with tBAP2
alone was ampliﬁed using the primers ACTAGTATGCTATCTTCAGAAG
ATTTTGGATCTTCTGG and ATAGGGTACCTTCATGATGGCCTCCTAGTCSource or reference
[19]
Provided by A. Kihara
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into the pGEM-T Easy vector to yield pYU134. The pTDH3 of pAK162
was replaced with pBAP2, which was generated using the primers
CGGGCCCCCCCTCGAGGGGCTTTCGTTGCCACTCTTCAGGAT and ACTCAT
GGTTCCCCCGGGGAGTTTTATTGAAGCTAAATAAATTGATAGTATCG from
pYU1 as a template, to yield pUA134. Finally, the SpeI-digested DNA
fragment from pYU13 was introduced into pUA135 to yield pYU65
(pBAP2-3HA-BAP2-tBAP2 [CEN4 URA3]), which was used for Western
blot analyses.
To generate a BAP2-GFP plasmid, the pBAP2-3HA-BAP2 region was
ampliﬁed using the primers CTCACCATGGTGCCCGGGCACCAGAAATGA
TAAGCTTTTCTCATCAA and TGCTCACCATGGATCCACACCAGAAATGAT
AAGCTTTTCTCATC and pYU65 as a template. The resulting DNA
fragment was introduced into pUA99 (EGFP-tTDH3, CEN4 URA3) to
yield pUA196 (pBAP2-3HA-BAP2-EGFP-tTDH3 [CEN4 URA3]), which
was used for ﬂuorescence microscopic analyses.
PCR-based site-directed mutagenesis was performed to create
amino acid substitutions in the Bap2 TMDs, using PrimerSTAR Max
(TaKaRa Bio Inc., Otsu, Shiga, Japan), relevant primers, and pYU65 as a
template. The appropriate base substitutionwas conﬁrmed by sequenc-
ing the BAP2 ORF with the relevant sequence primers. The resulting
3HA-BAP2 ORFs were introduced into pUA99 to yield the mutant
forms of the 3HA-BAP2-GFP plasmids.
2.3. Western blotting
Whole cell extract preparation was performed as described
previously, with a slightmodiﬁcation [20]. In brief, 108 cells in the expo-
nential growth phase (1.0–1.5 × 107 cells·mL−1) were collected by
centrifugation, washed serially with 10 mM NaN3–10 mM NaF and
lysis buffer A (50 mM Tris–HCl, 5 mM EDTA, 10 mM NaN3, 1 mM
PMSF, and 1 Complete™ EDTA-free tablet [Roche, Mannheim,
Germany] for 50 mL, pH 7.5), and disrupted with glass beads at 4 °C.
Unbroken cells and debris were removed by centrifugation at 900 ×g
for 5 min, and the cleared lysates were treated with 5% SDS–5%
2-mercaptoethanol at 37 °C for 10 min to denature the proteins. To ob-
tain the P13membrane fraction, the whole cell extracts were subjected
to centrifugation at 13,000 ×g for 10min, and the resulting pellets were
treated with 5% SDS–5% 2-mercaptoethanol at 37 °C for 10 min. Anti-
bodies against hemagglutinin (HA; InvivoGen, San Diego, CA, USA),
Pma1 (40B7, Abcam, Cambridge, UK), Pep12 (2C3G4, Abcam), and
Dpm1 (5C5A7, Life Technologies Corp., Carlsbad, CA, USA) were used.
Adh1 and Pma1were used as loading controls for thewhole cell extracts
and the P13membranes, respectively. Dpm1was used as a loading con-
trol for both the P13 and P100 membranes. The signals were detected
with an ImageQuant LAS4000 mini (GE Healthcare Life Sciences,
Piscataway, NJ, USA).
2.4. Subcellular fractionation
Cellswere fractionatedusingdifferential centrifugation, as described
previously [20]. Whole-cell lysates, prepared as described above, were
subjected to centrifugation at 13,000 ×g for 10 min to yield a P13
(pellet) fraction. The resulting supernatant fractionwas subjected to cen-
trifugation at 100,000 ×g for 30 min to yield a P100 (pellet) fraction. The
cells were also fractionated by centrifugation on a sucrose density gradi-
ent to separate the cellularmembranes. The cellswerewashed twicewith
10 mM NaN3, once with 10 mM Tris–HCl (pH 7.5)–10 mM NaN3, and
once with 100 mM Tris–HCl (pH 9.4)–40 mM 2-mercaptoethanol. The
cells were then resuspended in 50 mM Tris–HCl (pH 7.5)–1.2 M sorbitol
and treated with 2 mg·mL−1 of zymolyase 100 T for 30 min at 30 °C to
obtain spheroplasts. The spheroplasts were collected by centrifugation
and were homogenized with a 27-gauge needle 6 times. After removing
the unbroken cells by centrifugation, the cell lysate was placed on a
sucrose density gradient (30, 45, 50, 55, and 60%) for centrifugation at
256,000 ×g for 5 h. Five fractions (each 840 μL) were collected from thetop, and the proteins were treated with 5% SDS–5% 2-mercaptoethanol
at 37 °C for 10 min to denature the proteins.
2.5. Leucine import assay
L-[4, 5-3H] leucine (MT-672E, 5.18 TBq·mmol−1, 37 MBq·mL−1,
1.01 μg·mL−1; Moravek Biochemicals, Inc., Brea, CA, USA) was used
for the leucine import assay. This assaywas performed as described pre-
viously, with some modiﬁcations [17,21]. The cells were grown in SC
100Leu at 25 °C with shaking, washed twice, and resuspended in SC
40Leumedium, after which the cell culture wasmaintained for an addi-
tional 6 h. The cells were collected by centrifugation,washed twicewith
the assay buffer [50 mM 2-morpholinoethanesulfonic acid (Mes),
20 mM (NH4)2SO4, 2% D-glucose, pH 5.0], and resuspended in the
assay buffer with 4 μg·mL−1 leucine at a cell density of approximately
3 × 107 cells·mL−1. 3H-labeled leucine at a concentration of 1/1000 of
the total volume was added to the cell suspension to begin the assay.
A vacuum aspirator was used to trap 300 μL of cell suspension on
pairwise-stacked GF/C glass ﬁlters, followed by a wash step with
20 mL of ice-cold distilled water. The quantity of incorporated leucine
was then measured using a liquid scintillation counter. In our
experimental conditions (4 μg·mL−1 = 30.5 μM leucine), 1 DPM for
L-[4, 5-3H] leucine could be converted to 10.4 fmol of incorporated
non-labeled leucine in the cells. The data are expressed as the mean
values of incorporated amino acid (pmol·107 cells−1 min−1) and the
standard deviations were obtained from 3 independent experiments.
2.6. Fluorescence microscopy
Cells expressing GFP-tagged Bap2 proteins were imaged using a
ﬂuorescencemicroscope (model IX70; Olympus, Co. Ltd., Tokyo, Japan).
2.7. Structural modeling
The ESyPred3D Web Server 1.0 software (http://www.fundp.ac.be/
sciences/biologie/urbm/bioinfo/esypred/), an automated homology
modeling program with increased alignment performances based on
the modeling package MODELLER, was used [22,23]. The proﬁle query
for Bap2 yielded the E. coli arginine/agmatine antiporter AdiC (PDB
entries: 3LRB and 3L1L) as a structural template [15,16]. An alignment
was created for this template, and the Bap2 model was constructed
using the PyMOLMolecular Graphics System, Version1.5.0.4 Schrödinger,
LLC (http://www.pymol.org/) [24].
3. Results
3.1. bap2Δ cells exhibit defective growth in SC 40Leu medium
Before functionally analyzing Bap2 mutants, it was necessary to
establish an appropriate evaluation system. Because leucine could
potentially be imported by multiple amino acid permeases, including
Bap2, Bap3, Tat1, and Gap1, it was necessary to distinguish Bap2-
mediated leucine import from the others. The ssy1Δgap1Δ mutant
was reported to be defective in leucine uptake and exhibit a growth de-
ﬁciency similar to that of the bap2Δbap3Δtat1Δgap1Δ mutant when
grown on YPDmedium, in which leucine, isoleucine, and valine synthe-
sis was inhibited by metsulphuron methyl [10]. For the following
reasons, however, we did not employ the ssy1Δgap1Δ mutant to
evaluate Bap2 function in this study. First, the ssy1Δgap1Δmutant was
defective in the uptake of several amino acids, including tyrosine, gluta-
mate, tryptophan, serine, and methionine, in addition to the branched-
chain amino acids [10]. Second, the ssy1Δmutation is synthetic-lethal
when combined with the leu2 mutation, which is an auxotrophic
marker of the wild-type strain BY4741 [25]. Instead, we sought to
determine the critical leucine concentration in SC medium at which
only the bap2Δmutant exhibited growth defects. This would allow us
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Fig. 1. Cell growth and Bap2 protein expression under high and low leucine concentra-
tions. (A) Cell growth of the wild type (bap2Δ cells harboring a 3HA-BAP2 plasmid) and
bap2Δmutant strains (bap2Δ cells harboring an empty vector alone) in SC 100Leu or SC
40Leu medium. (B) Whole cell extracts from the wild type strain were subjected to
Western blot analysis to detect 3HA-Bap2 proteins. Whole cell extracts from the wild
type strain were subjected to differential centrifugation (C) or centrifugation on a sucrose
density gradient (D) to separate the membranes, followed by Western blot analysis.
(E) Visualization of Bap2-GFP proteins via ﬂuorescence microscopy. Adh1, Pma1, Dpm1,
and Pep12 were used as marker proteins for the cytoplasm, plasma membrane, ER, and
endosomes, respectively.
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conditions. While both the wild-type and bap2Δ strains grew equiva-
lently at a high leucine concentration (100 μg·mL−1), the bap2Δ cells
exhibited a slow growth phenotype at a low leucine concentration
(40 μg·mL−1) (Fig. 1A). However, both the wild-type and bap2Δ cellsexhibited defective growth at a very low leucine concentration
(4 μg·mL−1), likely because high isoleucine (30 μg·mL−1) and valine
(150 μg·mL−1) concentrations in the SC medium competed for leucine
uptake; additionally, 4 μg·mL−1 of leucine is an insufﬁcient concentra-
tion to fulﬁll the high demand for leucine during protein synthesis (data
not shown). Therefore, subsequent analyses were performed at 40 and
100 μg·mL−1 leucine in SC medium (SC 40Leu and SC 100Leu, respec-
tively). Unless otherwise speciﬁed, we kept cell culture in SC 40Leu
medium for 6 h. Hereafter, “wild type” denotes the bap2Δmutant that
carried 3HA-BAP2 in a centromere-based plasmid, and “bap2Δ” denotes
the bap2Δmutant that carried an empty vector alone.
There were no marked differences in the Bap2 protein levels be-
tween the cells grown in SC 100Leu and SC 40Leu media (Fig. 1B).
Whole cell extracts were subjected to differential centrifugation to
yield the P13 membrane fraction in which the majority of the plasma
membrane was retrieved, as well as the P100 membrane fraction in
which half-quantities of the endosomes and ER membranes were re-
trieved. Bap2 proteins were discovered not only in the P13 fraction,
but also to a lesser extent in the P100 fraction (Fig. 1C). There was little
difference in Bap2 distribution between cells grown in SC 100Leu and
those grown in SC 40Leu medium. We further subjected the whole
cell extracts to sucrose density gradient centrifugation to precisely frac-
tionate the internal membranes. We found that Bap2 co-localized with
both the plasma membrane marker Pma1 and the endosomal marker
Pep12, indicating that Bap2 is delivered to the cell surface and targeted
to the vacuoles for degradation through the endocytic pathway
(Fig. 1D). Few differences in Bap2 localization were observed in cells
grown under different leucine concentrations. As a convenientWestern
blot analysis method, we used the P13 membranes to examine the
levels of Bap2 mutant proteins, rather than isolating internal mem-
branes on a sucrose density gradient. To validate the Bap2 distribution
revealed by membrane fractionation, we conﬁrmed the localization of
Bap2-GFP to the plasma membrane and endosomes using ﬂuorescence
microscopy (Fig. 1E).
3.2. Rationale for mutation design
We have identiﬁed 15 amino acid residues that are required for
Tat2-mediated tryptophan import by means of random mutagenesis
and site-directed mutagenesis based on structural information about
E. coli AdiC [15–17]. Given the pronounced similarity, we rationalized
an examination of the Bap2 amino acid residues homologous to the 15
residues in Tat2. The amino acid sequences of the 5 permease proteins
are aligned in Fig. 2 [26]. TMD1,−3,−6,−8, and−10 were found to
be located interiorly in the overall folding structure of AdiC [15,16].
The AdiC substrate-binding motifs GSG (TMD1) and GVESA (TMD6)
were conserved in both Tat2 (GTG and GIEMT, respectively) and Bap2
(GTG and GMELF, respectively). Therefore, I109T, G110V, T111A,
L113S (TMD1), and E305D (TMD6) mutations were introduced into
Bap2. In particular, E305, a fully conserved amino acid residue among
yeast amino acid permeases, corresponds to E208 in AdiC, in which
this residue plays a central role in arginine transport as the distal gate
[15,16]. The central AdiC cavity comprises N22 and S26 from TMD1,
Y93 from TMD3, E208 from TMD6, and Y365 from TMD10, which corre-
spond to T107, T111 (TMD1), Y181 (TMD3), E305, andW469 (TMD10)
in Bap2, respectively. Therefore, Y181L and W469L mutations were in-
troduced into Bap2 along with T111A and E305D. K242 (TMD5) is also
fully conserved among yeast amino acid permeases, and therefore a
K242R mutation was introduced into Bap2. Gap1 is considered a
transceptor, or a transporter protein with a receptor function. S388
and V389 are amino acid restudies of which the side chain was shown
to protrude into the amino acid biding site of Gap1, and they were par-
tially required for amino acid activation of PKA pathway signaling [27].
The corresponding sites in TMD8weremutated in Bap2 to create S393G
and V394A, respectively; these residues are not conserved in AdiC. In
addition to these amino acid residues that were rationalized according
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Fig. 2. Sequence alignments of TMDα-helices 1,−3,−5–8, and−10 in Bap2, Bap3, Tat1, Tat2, and E. coli AdiC. The residuesmutated in this study are marked at the top. The alignments
were constructed with the PRALINE multiple-sequence alignment program [26]. TMD α-helices were assigned according to the crystallographic structures of AdiC (PDB: 3L1L) [16].
TMDα1 and TMDα6 are divided by anα-helix break to yield TMDα1a/TMDα1b and TMDα6a/TMDα6b, respectively, according to the AdiC structure (PDB: 3L1L) [16]. Amino acid residues
essential for Bap2-mediated leucine import are indicated by asterisks (*), and residues prone tomutation are indicated by dots (•).α denotes anα-helix. The numbers in the bottom rows
indicate consistency scores derived from PRALINE.
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TMD3, TMD7, and TMD10, for which the signiﬁcances were validated
in Tat2 [17]. These were C182A (TMD3), Y336L, I341L, I343L, F345L,
and V347L (TMD7). In total, 17 amino acid residues were individually
mutated in Bap2 (Fig. 2 and Table 2).Table 2
Mutated amino acid residues in Bap2 and corresponding Tat2 and AdiC residues.
Bap2 mutation TMD1) Bap2 function2) Correspondin
I109T 1 − I96T
G110V 1 − G97V
T111A 1 − T98A
L113S 1 + L100S
Y181L 3 − Y167L
C182A 3 + V168A
K242R 5 + K228R
E305D 6 − E286D
Y336L 7 − F315L
I341L 7 + T320L
I343L 7 + V322L
F345L 7 + F324L
V347L 7 + V326L
S393G 8 + S370G
V394A 8 − V371A
W469L 10 + W446L
T470A 10 + L447S
1) TMDs were assigned based on the crystallographic structure of AdiC (PDB: 3L1L).
2) Bap2 function was evaluated by the complementation test for growth in SC 40Leu medium.
−, no or poor growth; +, growth.
3) Tat2 function was evaluated by the complementation test for growth on SD 4Trp and YPD a
−, no growth; +/−, poor growth; +, growth.3.3. Functional analysis of Bap2 mutant proteins
Cells growing exponentially in SC 100Leu medium were diluted
in SC 100Leu or SC 40Leu medium to obtain 0.1 OD600 cell cultures
(approximately 1.65 × 106 cells·mL−1). The cells were cultured forg Tat2 mutation Tat2 function3) Corresponding AdiC residue
− M24
− G25
− S26
− V28
− Y93
− W94
− A158
− E208
− Y239
− T244
− I246
− G248
− I250
− G288
− S289
+/− Y365
+/− L366
gar plates (Ref. [17]).
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measureable differences in growth in SC 100Leu medium among these
strains; however, mutant strains carrying I109T, G110V, T111A, Y181L,
E305D, Y336L, or V394A single mutations in Bap2 exhibited signiﬁcant
growth defects in SC 40Leu medium (Fig. 3). These results suggested
that the 7 amino acid residueswere required for Bap2-mediated leucineBap2
Pma1
Bap2
Pma1
100 µg
40 µg
Fig. 4. Bap2 mutant protein expression. Bap2 mutant proteins were expressed in bap2Δ c
centrifugation at 13,000 ×g for 10 min. The membranes were subjected to Western blot analysimport. This was in sharp contrast to the ﬁnding that 15 amino acid
residues were required for Tat2-mediated tryptophan import.
To eliminate the possibility that any mutations diminished Bap2
synthesis and surface delivery, plasma membrane localization was
conﬁrmed in the 7 mutant proteins. Cells were grown in SC 100Leu or
SC 40Leu medium, and P13 membrane fractions were prepared from
whole cell extracts to enrich the plasmamembrane concentrations. De-
spite some variations in the levels, Bap2 proteins in both the wild-type
and mutant cells were almost equally localized in the P13 membranes
(Fig. 4). To support this result, Bap2-GFP fusion proteinswere expressed
in bap2Δ cells and visualized using ﬂuorescence microscopy. We con-
ﬁrmed that Bap2-GFP fusion proteins with I109T, T111A, Y181L,
Y336L, E305D, and V394Amutations localized to the plasmamembrane
aswell as did thewild type Bap2, thus justifying the growth analysis and
subsequent leucine import assay. However, Bap2-GFP fusion proteins
carrying G110Vmutation accumulated in the ER rather than the plasma
membrane (Fig. 5). Next, we noticed that GFP-fusion-Bap2G110V
or -Bap2E305D expression led to a prolonged initiation of bap2Δ cell
growth after the inoculation of cell aliquots from a SD agar plate into
SC 100Leu medium, which also occurred with the 3HA-tagged mutant
forms (data not shown). It is possible that the fused GFP caused Bap2
protein misfolding in the ER when combinedwith the G110Vmutation,
and G110V and E305D mutations might have exerted some stress on
the cells at the onset of cell growth.
3.4. Leucine uptake by Bap2 and the relevance of logP to substrate
recognition
Leucine uptake wasmeasured using 3H-labeled leucine. Initially, we
attempted to use SC 40Leu medium to compare the import activities of
the wild type and bap2Δ cells because the differences in their growth
rates were clearly distinguishable (Fig. 1A). Unexpectedly, bap2Δ
cells were able to import leucine as efﬁciently as the wild-type cells
(data not shown).We attempt to explain this puzzling result as follows.
In this assay, the cells were resuspended in fresh SC 40Leumedium that
contained 40 μg·mL−1 leucine. This might have allowed the low-
afﬁnity leucine permeases Bap3 and/or Tat1 present in bap2Δ cells to
import leucine. During the long-term incubation (more than several
hours; Fig. 1A), the cells gradually consumed leucine, and consequently
the leucine concentration decreased. In addition, the coexisting isoleu-
cine and valine competed against leucine import. Under these condi-
tions, only the high-afﬁnity leucine permease Bap2 could contribute to
leucine import to support cell growth. Eventually, the assay was per-
formed with a buffer [50 mM 2-morpholinoethanesulfonic acid (Mes),
20 mM (NH4)2SO4, 2% D-glucose, pH 5.0] that contained a low leucine/mL Leu
/mL Leu
ells grown in SC 100Leu or SC 40Leu medium. The P13 membranes were collected by
is to detect 3HA-Bap2 and Pma1 with speciﬁc monoclonal antibodies.
I109T DIC
100 µg/mL Leu 40 µg/mL Leu
G110V DIC
T111A DIC T111A DIC
Y181L DIC Y181L DIC
E305D DIC
Y336L DIC Y336L DIC
V394A DIC V394A DIC
WT DIC WT DIC
I109T DIC
G110V DIC
DICE305D
Fig. 5. Bap2 mutant protein localization. GFP-tagged Bap2 mutant proteins were
expressed in bap2Δ cells. Exponentially growing cells in SC 100Leu or SC 40Leu medium
were imaged via ﬂuorescence microscopy.
1725Y. Usami et al. / Biochimica et Biophysica Acta 1838 (2014) 1719–1729concentration (4 μg·mL−1) in the absence of isoleucine and valine,
rather than SC 40Leu medium (see theMaterials and methods section).
Cells were grown in either SC 100Leu or SC 40Leu medium, washed
twice, and resuspended in the import assay buffer that contained a
1/1000 volume of 3H-labeled leucine. The wild type cells imported
leucine at a rate of approximately 30 pmol 107·cells min−1 when
grown in either SC 100Leu or SC 40Leu medium (Fig. 6A). The bap2Δ
cells exhibited reduced leucine import activity when grown in SC
100Leu medium and defective import activity when grown in SC
40Leu medium. This result suggested that leucine permeases other
than Bap2were downregulated during culture in SC 40Leumedium. Ac-
cordingly, the import assay could effectively evaluate Bap2 activity
when SC 40Leu medium was used as the growth medium. The leucine
uptake was time-dependent and exhibited a linear dependence on the
incubation time for up to 10min, and therefore all subsequentmeasure-
ments were performed for 10 min (Fig. 6A).
To gain insight regarding substrate speciﬁcity, we measured
Bap2-mediated leucine import (leucine 4 μg·mL−1 = 30.5 μM) in thepresence of 10-fold higher concentrations (305 μM) of some non-
radiolabeled amino acids. As shown in Fig. 6B, 3H-labeled leucine import
was strongly inhibited by leucine, isoleucine, and phenylalanine and
moderately inhibited by methionine, tyrosine, valine, and tryptophan.
In contrast, histidine and asparagine did not cause inhibition. The order
of effect strengthwas phenylalanine, leucine N isoleucine N methionine,
tyrosine N valine N tryptophan. This result suggested that leucine, iso-
leucine, and phenylalanine were preferred high-afﬁnity substrates that
competed for Bap2. This ﬁnding agreed with a previous ﬁnding that
BAP2 overexpression under the control of the TPI1 promoter increased
the uptake of phenylalanine, leucine, isoleucine, methionine, tyrosine,
valine, and tryptophan but not histidine and arginine [28]. Next, we plot-
ted the degree of inhibition versus the molecular weights, hydropathy
indices that represent the hydrophobic or hydrophilic properties of the
side chain [29], or logP values (octanol–water partition coefﬁcient) of
these amino acids (Data Book of Molecules; http://www.ecosci.jp/ec.
html). We found that the degree of inhibition clearly correlated with
the logP of all amino acids except tryptophan and represented a correla-
tion coefﬁcient of R2 = 0.957 (Fig. 6C). Tryptophan deviated consider-
ably from the correlation curve obtained with the other 8 amino acids.
We assumed that the Bap2 substrate-binding site was hydrophobic and
thereby would accommodate amino acid side chains with certain
degrees of hydrophobicity and bulkiness. Importantly, the amino acid
hydropathy index exhibited a rather low correlation with the degree of
leucine import inhibition when compared with the logP (Fig. 6C). This
led to a hypothesis in which the free amino acid partition efﬁciency to
the buried binding pocket would be the primary determinant of the
broad range of Bap2 substrate speciﬁcity, rather than the side chain
property alone. Although it is speculative, our hypothesis would explain
the reduced requirement for amino acid residues in Bap2-mediated
leucine import, compared with that of Tat2-mediated import (see the
Discussion section).
Seven Bap2 mutations were selected for the import assay
according to the signiﬁcance of the associated growth defects; these
were I109T, G110V, T111A, Y181L, E305D, Y336L, and V394A. We
found that these mutations compromised leucine import to various
degrees in the following order of severity: G110V, T111A, E305D,
Y336L N Y181L, V394A N N I109T (Fig. 7). The defective import
severities agreed well with the growth abilities of the cells in SC 40Leu
medium (Fig. 3).
3.5. Functional mapping of amino acid residues on the modeled Bap2
structures
Bap2 structure models were based on the E. coli AdiC outward-open
(template, PDB 3LRB) [15] and occluded (template, PDB 3L1L) [16]
structures, as previously performed for Tat2 [17]. Overall, the modeled
Bap2 structures were similar to those of Tat2, except that the Bap2
TMD12 did not form an obvious α-helix structure (Fig. 8). There was a
putative trajectory of leucine translocation within the Bap2 outward-
open model. AdiC is known to undergo major conformational changes
in TMD2, TMD6, and TMD10 upon arginine binding, resulting in the
substrate-binding occluded conformation [16]. Correspondingly, struc-
tural conversion from the outward-open to the occluded structure
was observed in Bap2. The 7 critical amino acid residues were mapped
onto the Bap2 structural models (Fig. 8). I109, G110, and T111
(TMD1)were located within or adjacent to the GTGmotif, which corre-
sponds to theGSGmotif of AdiC. The GSGmotif of AdiC is locatedwithin
the TMD1 helix-break region and fulﬁlls a role in arginine carboxyl
group recognition [16]. Hence, the signiﬁcance of Bap2 I109, G110,
and T111 is considered the recognition of the leucine carboxyl group.
In Bap2, a contiguous L113S mutation had no effect on leucine import,
whereas the corresponding L100Smutation diminished tryptophan im-
port. T111, Y181 (TMD3), and E305 (TMD6) were assumed to form the
central cavity of Bap2, and mutations in these amino acid residues
abolished leucine import. The C182A mutation had no effect on leucine
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4 μg·mL−1 (30.5 μM) of non-labeled leucine (see the Materials and methods section). (B) A leucine import assay was performed in the presence of 10-fold higher concentrations
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1726 Y. Usami et al. / Biochimica et Biophysica Acta 1838 (2014) 1719–1729import. The corresponding V168A mutation in Tat2 led to a more pro-
nounced defect in tryptophan import, comparedwith tyrosine and phe-
nylalanine import, in turn suggesting that V168 plays a partial role in
the tryptophan selectivity of Tat2 [17]. Accordingly, C182 is unlikely to
engage in leucine aliphatic side-chain recognition. In the modeled
Bap2 structure, K242 (TMD5) faced I109 and G110, but the K242R mu-
tation had no marked effect on leucine import. In contrast, the K228R
mutation diminished tryptophan import by Tat2 [17]. Therefore, a pos-
itive charge at position 242 (K242 or R242)might be sufﬁcient for Bap2,
but lysine is required at position 228 in Tat2 and might possibly affectsubstrate recognition by the GTG motif. Amino acid residues in TMD7
have not been addressed in AdiC studies. Among the 5 mutations in
TMD7 (Y336L, I341L, I343L, F345L, and V347L), only the Y336L muta-
tion compromised leucine import. This is in sharp contrast to the signif-
icance of TMD7 in Tat2-mediated tryptophan import [17]. S393 (TMD8)
and V394 (TMD8) are highly conserved in yeast amino acid permeases.
In Gap1, S388 and V398 are exposed to the putative amino acid translo-
cation pathway and are assumed to stimulate the PKA pathway upon
nutrient addition to the cells [27]. However, in Bap2, V394 but not
S393 was required for leucine import.
0 
20 
40 
60 
80 
Up
ta
ke
 (p
mo
l   
10
7 
ce
lls
-
1 
  m
in
-
1 )
Fig. 7. Effects of Bap2 mutations on leucine import. Exponentially growing cells in SC
100Leu medium were shifted to SC 40Leu medium, followed by an additional 6-h incuba-
tion. Leucine uptake was measured as described in the Materials and methods section.
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Among the yeast amino acid permeases with leucine-transport
capability, we focused on the high-afﬁnity leucine permease Bap2.
Based on our prior observations with Tat2, we identiﬁed 7 amino acid
residues required for leucine import in Bap2. Accordingly, Bap2 was
more permissive to amino acid substitution than was Tat2 with respectOutward-open 
(substrate free)
I109
T111 G110
Y
E3
Y336
V394
Y
E3
V394
Y336
I109
T111
G110
Side
Top
Putative tra
Fig. 8. Structural models of Bap2. Overall structures of Bap2 based on the AdiC outward-open (le
structures. Seven essential amino acid residues for leucine import are shown. The putative trajto the critical sites conﬁrmed in the Tat2 analysis. Further experiments
are needed to verifywhether these amino acid residues directly interact
with leucine or indirectly affect substrate recognition or transport. In
our previous study, we showed that tryptophan import was highly sen-
sitive to high hydrostatic pressure [20], whereas leucine import was
almost unaffected by pressure up to 50 MPa [30]. High pressure stiffens
the lipid membranes [31], and thereby the TMD conﬁgurations of any
membrane proteins are affected to some extent. The pronounced
high-pressure sensitivity of Tat2 might be attributable to a delicate
mechanism of tryptophan recognition and translocation, mediated by
rigorous interactions between the substrate-binding site and the trypto-
phan side chain. In this light, the high-pressure resistance of Bap2might
agree with the fact that reduced numbers of amino acid residues were
required for leucine import. The effects of hydrostatic pressure on an
enzymatic reaction are interpreted by the simplest kinetic mechanism
in which the transition state presents the highest energy barrier, and
the chemical transformation of substrate to product is considered to
be a single rate-limiting step [32,33]. Assuming that an amino acid is
imported based on the simplest model, the differential effects of high
pressure on Tat2 and Bap2 could also be attributable to the difference
in conformational changes of the permease proteins associated with
the substrate import; Tat2 undergoes a more pronounced conforma-
tional change than Bap2 does to form the transition-state ensemble.
It is worthwhile elucidating whether any Bap2 mutations affect
the high-pressure resistance of leucine import. Bap2-mediated high-
afﬁnity leucine import was inhibited by phenylalanine, leucine, isoleu-
cine, methionine, tyrosine, valine, and tryptophan, which was consis-
tent with the previous report in which BAP2 overexpression enhanced
the uptake of these amino acids [28]. One notable ﬁnding is that leucine
import inhibitionwas clearly dependent on the logP values of the amino
acids, except tryptophan. Hence, we proposed a working hypothesisTMD 
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Bap2 selectivity, rather than the side-chain size or architecture alone.
This might account for the broad substrate speciﬁcity observed for
Bap2 in comparison to Tat2, which in turn suggests that Tat2 evolved
as a distinct system to facilitate tryptophan uptake.
LeuT is a bacterial homologue of the neurotransmitter::sodium
symporter family and has been successfully characterized by X-ray
crystallography [34]. LeuT functions as a sodium-dependent symporter
that is capable of transporting many hydrophobic amino acids, ranging
from glycine to tyrosine. A requirement for a potential LeuT molecular
substrate is that it must ﬁt within the occluded substrate-binding cavity.
Tryptophan is too large to be accommodatedwithin this cavity and even-
tually becomes a non-transposable competitive inhibitor for LeuT. The
LeuT–tryptophan complex adopts an open-to-out conformation because
of the bulky size of tryptophan relative to the binding site. Singh et al.
demonstrated that [3H]-leucine binding to LeuT was inhibited by
multiple aliphatic and aromatic amino acids of varying sizes in the follow-
ing order of severity: leucine (−1.52) N methionine (−1.87) N alanine
(−2.85) N tyrosine (−2.26) N tryptophan (−1.05) N glycine (−3.21;
logP values are noted in parentheses) [35]. From their results, we noticed
that the severity also roughly coincided with the logP values, except for
tryptophan. In LeuT, the F259 and I359 side chains participate in van
der Waals interactions with the leucine side chain. The I359Q mutation
in LeuTwas shown to convert the activity of tryptophan froman inhibitor
to a transportable substrate, thus allowing the formation of the occluded
state. The I359Qmutation introduces both steric and electrostatic chang-
es in the LeuT binding site [35]. In rats, the L-type amino acid transporter 1
(LAT-1) is a Na+-independent neutral amino acid transporter with broad
speciﬁcity [36]. LAT-1-mediated phenylalanine import was strongly and
competitively inhibited by aromatic amino acid derivatives such as
L-dopa,α-methydopa,melphalan, triiodothyronine, and throxine,where-
as phenylalanine methyl ester, N-methyl phenylalanine, dopamine,
tyamine, carbidopa, and droxidopa did not inhibit phenylalanine import
[37]. These inhibitory derivatives must contain free carboxyl and amino
groups, and are also accompanied by a calculated logP value within a
certain range (−0.1896 to 0.7654), with some exceptions. From this
perspective, logP is a unique parameter that introduces the possibility of
developing competitive inhibitors not only for yeast Bap2, but also for a
broad range of amino acid permeases. To validate our hypothesis, we
must determine the kinetic parameters for a series of amino acids in
Bap2-mediated high-afﬁnity leucine import.
The severity of the GTGmotif mutations (I109T, G110V, and T111A)
was inevitable, given the role of arginine carboxyl group recognition at
the TMD1 helix-breaking region in AdiC. Near the Bap2 GTGmotif, Y336
(TMD7) might donate π electrons to I109 for structural stabilization, as
postulated for Tat2 (π–aliphatic chain interactions) [17]. This would
account for the defective leucine import observed in the Y336L mutant.
In the layer distal to the periplasm in AdiC, Y93 (TMD3), E208 (TMD6),
and Y365 (TMD10) played a central role in arginine transport as the
distal gate [16]. The hydrogen bond network surrounding E208 was
thought to lock the 3 TMDs in a closed conformation, thus blocking sub-
strate transport. Arginine binding is thought to disrupt interactions be-
tween E208 and Y93/Y365, thus causing additional changes in TMD3
and TMD10 to form the inward-open conformation of AdiC [16]. In
this regard, the Y181L and E305D mutations are likely to compromise
the conformational change in the TMDs upon leucine binding to Bap2.
E305 is highly conserved among yeast amino acid permeases and
bacterial solute transporters, and hence this glutamate residue is as-
sumed to play a central role across a broad substrate import range
[17]. We proposed two working hypotheses in Tat2 suggesting that
protonation/deprotonation of the E286 (E305 in Bap2) carboxyl group
mediated proton inﬂux coupled with tryptophan import [17], which is
likely applicable to Bap2. First, the pKa of glutamate is approximately
4.07 in water, and hence the majority of the carboxyl group will
be deprotonated at a neutral pH. Because proton extrusion by the
plasma membrane H+-ATPase Pma1 occurs to a great extent, thejuxtamembrane extracellular region might become more acidic than
the growth medium (pH 5–6). If the juxtamembrane pH is much less
than 4, the E305 carboxyl chain of Bap2 could be protonated in the
outward-open structure. Upon leucine binding, Bap2 would undergo a
structural change to form the inward-open structure, and concomitant-
ly protonswould be released to the cytoplasm. Second, E305 is buried in
the middle of the TMD6 helix, where the ambient dielectric constant
(D) becomes much lower than that of water (Dwater, approximately
80). Hence, the pKa of the E305 carboxyl group becomes much higher
than 4.07 and thereby the carboxyl group can be loaded with a proton,
even at a neutral pH [17]. The hypothetically high pKa value of E305 in a
low dielectric membrane environment is in accordance with a recent
report stating that pKa values of the glutamate residues buried within
a staphylococcal nuclease protein were high (range, 5.2–9.4 and
average, 7.7) [38]. In very large-scale studies, protonation of the E. coli
lactose permease LacY was shown to precede sugar binding at a physi-
ological pH and to exhibit a remarkably high pKa (approximately 10.5)
for sugar binding [39]. In LacY, multiple amino acid residues, including
Y236 (TMD7), E269 (TMD8), R302 (TMD4), H322 (TMD10), and E325
(TMD10), play central roles in proton translocation, but any single res-
idue is unlikely to be responsible for the unique pHdependence of sugar
binding [39]. These residues are located in the C-terminal 6-helix bun-
dle and positioned in the approximate middle of the LacY molecule
across from the sugar-binding site. Likewise, multiple amino acid resi-
dues located near E305 might also be involved in proton translocation
through Bap2.
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